Trials / Completed
CompletedNCT02337010
Continuous Central Venous Oxygen Saturation Assisted Intraoperative Hemodynamic Management
Continuous Central Venous Oxygen Saturation Assisted Intraoperative Hemodynamic Management During Major Abdominal Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Domonkos Trásy · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients who are scheduled for: elective oesophageal tumour resection, total gastrectomy, pancreas resection, major vascular, total cystectomy will be recruited.To investigate effects of central venous pressure (CVP) and central venous saturation (ScvO2) guided fluid management on intraoperative haemodynamic parameters, volume and vasopressor requirement, and postoperative organ function and postoperative inflammatory response.
Conditions
- Major Abdominal Surgery
- Perioperative Haemodynamic Monitoring
- Perioperative Fluid Management
- Perioperative Vasopressor Requirement
- Postoperative Organ Function
- Postoperative Complications
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CeVOX | Central venous saturation was continuously monitored by using a CeVOX monitor (Pulsion Medical Systems, Munich, Germany). The CeVOX probe (PV2022-37; Pulsion Medical Systems, Munich, Germany) was inserted into the internal jugular central venous catheter as described in the user's manual. |
| DEVICE | CVP | Central venous pressure was continuously monitored by using a central venous catheter. The probe was inserted into the internal jugular central vein as described in the user's manual. |
| DRUG | Fluid bolus | If hypovolaemia was suspected fluid bolus was given in the form of 250 ml hydroxyethyl starch solution (HES, 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride, Voluven, Fresenius Kabi, Germany) over 15 minutes. |
| DRUG | Vasopressor | If hypotension was present it was treated with vasopressor as 10 mcg bolus or continuous infusion of norepinephrine (Arterenol® Sanofi, Germany). |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2015-01-13
- Last updated
- 2015-01-13
Locations
1 site across 1 country: Hungary
Source: ClinicalTrials.gov record NCT02337010. Inclusion in this directory is not an endorsement.